Title: Adenosine for wide-complex tachycardia: Efficacy and safety*
Abstract: Objectives: To determine whether adenosine is useful and safe as a diagnostic and therapeutic agent for patients with undifferentiated wide QRS complex tachycardia. The etiology of sustained monomorphic wide QRS complex tachycardia is often uncertain acutely. Design: A retrospective observational study. Setting: Treatment associated with emergency visits at nine urban hospitals. Patients: Consecutive patients treated with adenosine for regular wide QRS complex tachycardia between 1991 and 2006. Interventions: Treatment with adenosine infusion. Measurements and Main Results: Measured outcomes included rhythm response to adenosine, if any, and all adverse effects. A positive response was defined as an observed change in rhythm including temporary atrioventricular conduction block or tachycardia termination. A primary adverse event was defined as emergent electrical or medical therapy instituted in response to an adverse adenosine effect. A rhythm diagnosis was made in each case. The characteristics of adenosine administration as a test for a supraventricular as opposed to ventricular tachycardia were determined, and the adverse event rates were calculated. A total of 197 patients were included: 104 (90%) of 116 (95% confidence interval, 83%–95%) and two (2%) of 81 (95% confidence interval, 0.3%–9%) supraventricular tachycardia and ventricular tachycardia patients demonstrated a response to adenosine, respectively. The odds of supraventricular tachycardia increased by a factor of 36 (95% confidence interval, 9–143) after a positive response to adenosine. The odds of ventricular tachycardia increased by a factor of 9 (95% confidence interval, 6–16) when there was no response to adenosine. The rate of primary adverse events for patients with supraventricular tachycardia and ventricular tachycardia was 0 (0%) of 116 (95% confidence interval, 0%–3%) and 0 (0%) of 81 (95% confidence interval, 0%–4%), respectively. Conclusions: Adenosine is useful and safe as a diagnostic and therapeutic agent for patients with regular wide QRS complex tachycardia.
Publication Year: 2009
Publication Date: 2009-08-13
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 52
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot